36
7
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3941 |
Choline Fenofibrate
Trilipix,ABT-335,非诺贝特胆碱 |
P450; COX; PPAR | DNA Damage/DNA Repair; Immunology/Inflammation; Metabolism; Neuroscience |
Choline Fenofibrate (Trilipix) 是 Fenofibric acid 的胆碱盐,在胃肠道中释放游离的 Fenofibric acid。Fenofibric acid 是一种合成的苯氧基异丁酸衍生物和具有抗高血脂活性的前药。 | |||
T25828 |
Monatepil maleate
AJ2615 maleate,AJ-2615 maleate,AJ 2615 maleate |
Calcium Channel; Adrenergic Receptor; Acyltransferase | GPCR/G Protein; Membrane transporter/Ion channel; Metabolism; Neuroscience |
Monatepil maleate (AJ-2615 maleate) 是一种具有口服活性的 Ca2+-通道和α1-肾上腺素受体拮抗剂,也是非竞争性肝酰辅酶A:胆固醇酰基转移酶(ACAT)抑制剂,具有抗高血压活性。Monatepil maleate 可用于研究高脂血症和动脉粥样硬化。 | |||
T28882 |
Sultosilic acid piperazine salt
Piperazine-sultosylate,A-585,Mimedran,A585,A 585 |
Others | Others |
Sultosilic acid piperazine salt (A-585) 是一种新型降脂化合物,可用于研究IIb型家族性联合高脂血症。 | |||
T24865 |
Tenivastatin
L-654969,L654969,Simvastatin acid,L 654969,Simvastatin hydroxy acid |
ROS; HMG-CoA Reductase | Immunology/Inflammation; Metabolism |
Tenivastatin (Simvastatin acid) 是一种抗高脂血症的 HMG-CoA 还原酶抑制剂,抑制活性氧 (ROS) 产生,可用于研究原发性高脂血症。 | |||
T4628 |
Seladelpar
MBX 8025 |
PPAR | DNA Damage/DNA Repair; Metabolism |
Seladelpar (MBX 8025) 是一种有效的,具有口服活性的, 特异性PPAR-δ激动剂,EC50为 2 nM。 | |||
T27832 |
Lifibrol
U 83860,K-12148,K-12.148,U-83860,K12148 |
Lipid | Metabolism |
Lifibrol (U-83860) 是一种胆固醇合成抑制剂。Lifibrol 具有抗胆固醇和降血脂的作用,可促进高胆固醇血症和混合型高脂血症患者体内低密度脂蛋白载脂蛋白 B-100 的转化。 | |||
T1162 |
Acipimox
Olbemox,K-9321,阿西莫司,阿昔莫司 |
Others | Others |
Acipimox (K-9321) 是烟酸类似物,能够急性抑制脂解作用,抑制全身游离脂肪水平,改善胰岛素敏感性。 | |||
T27245L |
Eflucimibe
L0081,F-12511 |
Acyltransferase | Metabolism |
Eflucimibe (L0081) 是一种酰基辅酶A:胆固醇酰基转移酶抑制剂,可用于治疗心血管疾病和内分泌与代谢疾病,可用于研究动脉粥样硬化和高脂血症。 | |||
T1604 |
Tiratricol
3,3',5-Triiodothyroacetic acid,替拉曲可 |
Thyroid hormone receptor(THR) | Endocrinology/Hormones |
Tiratricol (3,3',5-Triiodothyroacetic acid) 是 T3 和 T4 甲状腺激素的代谢物;促进高脂血症、局部脂肪营养不良和肥胖。它已用于研究 Allan-Herndon-Dudley 综合征治疗的试验。 | |||
T67974 |
Berberine ursodeoxycholate
HTD1801,BUDCA |
Others | Others |
Berberine ursodeoxycholate (HTD1801) 是一种口服有效的降血脂剂 ,是 Berberine 和 Ursodeoxycholic acid 的一种离子盐。Berberine ursodeoxycholate 具有广泛的代谢活性,可显著降低肝脏脂肪含量。Berberine ursodeoxycholate 可用于研究高脂血症、非酒精性脂肪性肝炎 (NASH) 和糖尿病。 | |||
T72025 |
PCSK9-IN-10
|
Serine/threonin kinase | Cell Cycle/Checkpoint; Metabolism |
PCSK9-IN-10 是一种有效的,具有口服活性的PCSK9抑制剂,IC50值为 6.4 µM。PCSK9-IN-10 增加LDLR 蛋白的表达并降低 PCSK9 的表达。PCSK9-IN-10 可减缓动脉粥样硬化进展。PCSK9-IN-10 具有研究高脂血症的潜力。 | |||
T38483 |
Omzotirome
TRC-150094 |
Others | Others |
Omzotirome (TRC150094) is a functional analog of iodothyronines and holds potential for research on hyperlipidemia (WO2008149379). | |||
T30110 |
AR 12456
AR12456,AR-12456 |
Others | Others |
AR-12456 is a Trapidil derivative that prevents serum hyperlipidemia in guinea pigs. | |||
T11914 |
LY88074 Trimethyl ether
|
Others | Others |
LY88074 Trimethyl ether is useful for inhibiting various conditions associated with estrogen deprivation syndrome, such as osteoporosis and hyperlipidemia. | |||
T26819 |
Binifibrate
WAC104,WAC 104,Antopal,WAC-104,Biniwas |
Others | Others |
Binifibrate is a hyperlipemiant drug used for the treatment of hyperlipidemia. | |||
T23611 |
Acetiromate
Adecol |
Others | Others |
Acetiromate is a drug of antilipidemic. It is used to treat hyperlipidemia. | |||
T28820 |
SMP-797 HCl
SMP-797,SMP 797,SMP797 |
Others | Others |
SMP-797 HCl, an ACAT (acyl-CoA-cholesterol acyltransferase) inhibitor, is used potentially for the treatment of Hyperlipidemia. | |||
T28825 |
Sodelglitazar
GW677954,GSK-677954 |
Others | Others |
Sodelglitazar, a PPAR agonist, is used potentially for the treatment of hyperlipidemia and type 2 diabetes. | |||
T11913 |
LY88074 Methyl ether
|
Others | Others |
LY88074 Methyl ether is effective in inhibiting conditions associated with estrogen deprivation syndrome, such as osteoporosis and hyperlipidemia, which occur due to various estrogen-deficient states. | |||
T39122 |
Inclisiran
ALN-PCSsc |
Others | Others |
Inclisiran (ALN-PCSsc) is a double-stranded small interfering RNA (siRNA) compound that effectively suppresses PCSK-9 transcription. It proves promising in the investigation of hyperlipidemia and cardiovascular disease (CVD). | |||
T74754 |
FXR antagonist 2
|
Others | Others |
Compound A-26, also known as FXR antagonist 2, is a diarylamide derivative that functions as a moderate FXR antagonist. It is utilized in researching hyperlipidemia and type 2 diabetes [1]. | |||
T11448 | GOAT-IN-1 | Others | Others |
GOAT-IN-1 is an inhibitor of ghrelin O-acyltransferase (GOAT), which could be useful for the prophylaxis or treatment of diabetes, hyperlipidemia, non-alcoholic fatty liver, Alzheimer’s disease, Parkinson’s disease, cerebrovascular dementia, cerebral infa | |||
T77113 | Ongericimab | ||
Ongericimab (JS002),一种人源化抗PCSK9单克隆抗体,可用于高胆固醇血症和高脂血症的研究,具有降脂功效。 | |||
T61430 |
S-2E
|
Others | Others |
S-2E is a compound that functions as an orally active, noncompetitive inhibitor of both HMG-CoA reductase and acetyl-CoA carboxylase. It exhibits an anti-hyperlipidemic action, making it suitable for studying conditions such as familial hypercholesterolemia and mixed hyperlipidemia [1] [2]. | |||
T60764 |
PCSK9 modulator-4
|
Others | Others |
PCSK9 modulator-4 (Compound 21) 是可以用于高血脂研究的,PCSK9的有效调节剂 (EC 50 = 0.15 nM)。PCSK9 是得到验证的一种降低低密度脂蛋白胆固醇 (LDL-C) 的靶标。 | |||
T74248 |
AS-Inclisiran
|
Others | Others |
AS-Inclisiran为Inclisiran的反义链。Inclisiran(ALN-PCSsc)为双链小干扰RNA(siRNA)分子,目的在于抑制PCSK-9的转录,适用于高脂血症及心血管疾病(CVD)的研究。 | |||
T74876 |
GalNAc unconjugated/naked Inclisiran
|
Others | Others |
GalNAc unconjugated/naked Inclisiran 是一种未偶联GalNAc的双链小干扰RNA (siRNA) 分子,具有抑制PCSK-9转录功能。该化合物主要应用于高脂血症及心血管疾病(CVD)的研究领域。 | |||
T60541 |
PCSK9 modulator-2
|
Others | Others |
PCSK9 modulator-2 (Compound 1) 是一种有效的PCSK9调节剂(EC50 = 202 nM), 具有用于高脂血症的研究潜力。PCSK9 是降低低密度脂蛋白胆固醇 (LDL-C) 的靶点。 | |||
T60646 |
PCSK9 modulator-3
|
Others | Others |
PCSK9 modulator-3 (Compound 13) 是PCSK9的有效调节剂,EC50值为 2.46 nM,在高脂血症研究中具有潜力。PCSK9 是已证实的降低低密度脂蛋白胆固醇 (LDL-C) 的靶点。 | |||
T84567 |
5(S)-HEPE
|
Others | Others |
5(S)-HEPE, an active metabolite of eicosapentaenoic acid (EPA), is produced via the action of 5-lipoxygenase (5-LO). This compound functions as an agonist for G protein-coupled receptor 119 (GPR119), promoting cAMP accumulation in CHO-K1 cells expressing human GPR119 at 10 µM concentration. Additionally, 5(S)-HEPE enhances glucose-stimulated insulin secretion from MING6 insulinoma pancreatic islets and glucagon-like peptide 1 (GLP-1) secretion from HuTu 80 adenocarcinoma cells at the same concen... | |||
T72889 |
FXR agonist 4
|
Others | Others |
FXR agonist4,一种法尼酯X受体(FXR)激动剂,具有1.05 μM的EC50值。该化合物在DIO小鼠模型中有效地改善了高脂血症、肝脏脂肪变性、胰岛素抵抗以及肝脏炎症,因此可用于非酒精性脂肪性肝病(NAFLD)的研究。 | |||
T63515 |
THR-β agonist 4
|
Others | Others |
THR-β agonist 4 是 THR-β 的有效激动剂。THR-β agonist 4 对代谢疾病表现出研究潜力,如高脂血症、肥胖、高胆固醇血症、糖尿病和其他病症如脂肪变性和非酒精性脂肪性肝炎 (NASH)、动脉粥样硬化和其他相关病症和疾病 。 | |||
T63697 |
THR-β agonist 3
|
Others | Others |
THR-β agonist 3 是 THR-β 的有效激动剂。THR-β agonist 3 对代谢疾病表现出研究潜力,例如肥胖、高脂血症、高胆固醇血症、糖尿病和其他病症如脂肪变性和非酒精性脂肪性肝炎 (NASH)、动脉粥样硬化和其他相关病症和疾病。 | |||
T79454 |
Anti-NASH agent 1
|
PPAR | DNA Damage/DNA Repair; Metabolism |
Anti-NASH agent 1 (compound 3d),Elafibranor衍生物,高效PPAR-α/δ激动剂,针对非酒精性脂肪性肝炎(NASH)。以3-10 mg/kg剂量,连续4周处理,能显著改善蛋氨酸胆碱缺乏(MCD)诱导的NASH小鼠高脂血症、肝脏脂肪变性及炎症状况,展现出低肝毒性和良好肝脏保护效能。 | |||
T74583 |
Desmethylazelastine
|
Others | Others |
Desmethylazelastine是Azelastine经由细胞色素P450酶系统的氧化代谢形成的主要活性代谢物,具有97%的蛋白结合率和54小时的消除半衰期。Azelastine作为一种口服活性的组胺H1受体拮抗剂,特点是选择性高和亲和力强。它主要用于治疗过敏性鼻炎、哮喘、糖尿病高脂血症以及用于SARS-CoV-2的研究。 | |||
T84609 |
(±)5(6)-DiHET
(±)5,6-DiHETrE |
Others | Others |
5(6)-DiHET is a racemic compound synthesized through the action of epoxide hydrolases on 5(6)-EET, encompassing both enantiomeric forms. It serves as a quantitative marker for 5(6)-EET, facilitating its measurement by utilizing the compound's conversion to 5(6)-δ-lactone in solution. Additionally, 5(6)-DiHET activates large-conductance calcium-activated potassium (KCa1.1/BK) channels in rat small coronary artery smooth muscle cells, supporting its biological significance in vascular regulation. ... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T2824 |
Pedunculoside
|
Others; Fatty Acid Synthase | Metabolism; Others |
Pedunculoside 是从 Ilex rotunda Thunb 中提取的,通过对脂质形成和脂肪酸 β-氧化的调节而发挥降脂作用。 | |||
T2321 |
Protodioscin
Furostanol I,原薯蓣皂苷 |
Androgen Receptor; Endogenous Metabolite | Endocrinology/Hormones; Metabolism |
Protodioscin (Furostanol I) 是一种山药根茎中的主要甾体皂苷,具有抗高血脂、抗癌活性。 | |||
T8306 |
Epiberberine chloride
|
Antioxidant; BACE; AChR; AChE | Neuroscience; oxidation-reduction |
Epiberberine chloride 是一种来自Coptis chinensis Franch.的天然原小檗碱,是 AChE、 BChE 和 BACE1 抑制剂,IC50 值分别为 1.07,6.03 和 8.55 μM。Epiberberine chloride 具有抗氧化作用,抑制Ca9-22和FaDu细胞系的运动,可用于研究高脂血症、阿尔滋海默症和糖尿病。 | |||
T3779 |
Crocin II
Crocin 2,西红花苷II,Crocetin gentiobiosylglucosyl ester,藏红花,Tricrocin,Crocin B |
Caspase; COX; NO Synthase | Apoptosis; Immunology/Inflammation; Neuroscience; Proteases/Proteasome |
Crocin II (Crocetin gentiobiosylglucosyl ester) 是从栀子果实中分离出来的一种天然产物,具有抗氧化、抗癌和抗抑郁活性。它抑制 iNOS 和 COX-2的蛋白质和 m-RNA 的表达,还抑制NO 产生,IC50值为 31.1 μM。 | |||
T3123 |
Allicin
|
ERK; IL Receptor; Others; IκB/IKK; p38 MAPK; TNF; ROS; Caspase; Antifection | Apoptosis; Immunology/Inflammation; MAPK; Microbiology/Virology; NF-κB; Others; Proteases/Proteasome |
Allicin 具有抗氧化、杀菌、抗癌、抗炎活性,对肠上皮细胞具有抑制性免疫调节作用。 Allicin 能显着抑制胰岛素诱导的血管平滑肌细胞的增殖和迁移,这可能与抑制 ERK 信号通路的激活有关。 Allicin 有利于降低高胆固醇血症大鼠的血液胆固醇、甘油三酯水平和收缩压,它可能有益于影响动脉粥样硬化的两个危险因素——高脂血症和高血压。 | |||
TN2372 |
Ethyl linolenate
亚麻酸乙酯,Linolenic acid ethyl ester |
Others | Others |
Linolenic acid ethyl ester is derived from bamboo leaves and perilla seeds. Has the effect of treating hyperlipidemia. | |||
T36563 |
(E)-Guggulsterone
|
Others | Others |
Bile acids are essential for solubilization and transport of dietary lipids, are the major products of cholesterol catabolism, and are physiological ligands for farnesoid X receptor (FXR), a nuclear receptor that regulates genes involved in lipid metabolism.1They are also inherently cytotoxic, as physiological imbalance contributes to increased oxidative stress.2,3Bile acid-controlled signaling pathways are promising novel targets to treat such metabolic diseases as obesity, type II diabetes, hy... |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71306 |
Gemfibrozil-d6
|
||
Gemfibrozil-d6 is intended for use as an internal standard for the quantification of gemfibrozil by GC- or LC-MS. Gemfibrozil is a peroxisome proliferator-activated reporter α and PPARγ agonist. In vivo, gemfibrozil reduces serum total cholesterol, triglyceride, and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia. Gemfibrozil reduces atherosclerotic plaque area, superoxide production, and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C) motif l... |